Cymbalta and Enterocolitis - a phase IV clinical study of FDA data

Summary:

Enterocolitis is reported as a side effect among people who take Cymbalta (duloxetine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Morphine Sulfate, and have Asthma.

The phase IV clinical study analyzes which people have Enterocolitis when taking Cymbalta. It is created by eHealthMe based on reports of 145,249 people who have side effects when taking Cymbalta from the FDA, and is updated regularly.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,973 Cymbalta users. Check the latest studies of Cymbalta.

What is Enterocolitis?

Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon) is found to be associated with 663 drugs and 731 conditions by eHealthMe. Check the latest studies of Enterocolitis.

On Jul, 18, 2026

145,249 people reported to have side effects when taking Cymbalta.
Among them, 19 people (0.01%) have Enterocolitis.

Among these 19 people:

How long have people been on Cymbalta when they have Enterocolitis? *

What is the gender of people who have Enterocolitis when taking Cymbalta? *

female: 94.44 %
male: 5.56 %

What is the age of people who have Enterocolitis when taking Cymbalta? *

What are other drugs people take besides Cymbalta? *

What are other side effects people have besides Enterocolitis? *

Diarrhea: 7 people, 36.84%
Hypokalemia (low potassium): 5 people, 26.32%
Heart Attack: 4 people, 21.05%
Constipation: 4 people, 21.05%
Conversion Disorder (neurological symptoms, such as numbness, blindness, paralysis, or fits without a definable organic cause): 3 people, 15.79%
Cardiomyopathy (weakening of the heart muscle): 3 people, 15.79%
Electrocardiogram Abnormal: 3 people, 15.79%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.79%
Infection: 3 people, 15.79%
Disinhibition (loss of inhibition): 3 people, 15.79%

What are the existing conditions these people have? *

Asthma: 5 people, 26.32%
Joint Pain: 4 people, 21.05%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 21.05%
Insomnia (sleeplessness): 4 people, 21.05%
Hypersensitivity: 3 people, 15.79%
Multiple Myeloma (cancer of the plasma cells): 3 people, 15.79%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 15.79%
High Blood Cholesterol: 3 people, 15.79%
High Blood Pressure: 3 people, 15.79%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take Cymbalta and have Enterocolitis?

- Check whether Enterocolitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cymbalta:

Cymbalta (154,973 reports)

Enterocolitis treatments and more:

Enterocolitis (7,684 reports)

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enterocolitis:

Enterocolitis (663 drugs)

Browse all the conditions that are associated with Enterocolitis:

Enterocolitis (731 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on duloxetine hydrochloride (the active ingredients of Cymbalta) and Cymbalta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.